MedChemComm · 2017 · 17 citations · 49 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyStructure-activity RelationshipsCatalytic MechanismsEnzyme DiscoveryEnzyme FunctionEnzyme InhibitionLigand BindingEnzyme Catalytic MechanismEnzyme Inhibition ScreeningEnzyme Inhibitor DiscoveryHost Immune SuppressionImmune Suppression MechanismsIndoleamine 2, 3-Dioxygenase PathwaySelectivityTherapeutic Target Identification
= 0.33-0.49 μM) in MDA-MB-231 cells. The cytotoxicity of these potent compounds was trivial in different model cancer (MDA-MB-231, A549 and HeLa) cells and macrophage (J774A.1) cells. Stronger selectivity for the IDO1 enzyme (124 to 210-fold) over the tryptophan 2,3-dioxygenase (TDO) enzyme was also observed for these compounds. These results suggest that the oxindole moiety of the compounds could mimic the epoxide intermediate state of l-Trp. Therefore, the structural simplicity and low-micromolar inhibition potencies of these 3-substituted oxindoles make them quite attractive for further investigation of IDO1 function and immunotherapeutic applications.
49
Osamu Takikawa, Takashi Kuroiwa, Fumio Yamazaki et al. · Journal of Biological Chemistry · 1988 · 472 citations · Full text
Hiroshi Sugimoto, Shun-ichiro Oda, Takashi Ôtsuki et al. · Proceedings of the National Academy of Sciences · 2006 · 426 citations · Full text